Meta description: Florfenicol API is a core veterinary phenicol antibiotic for livestock, poultry, and aquaculture formulations. Compare specifications, formulation compatibility, aquaculture market dynamics, and sourcing strategy for B2B buyers.

Primary keyword: florfenicol api

Secondary keywords: florfenicol raw material, florfenicol powder, florfenicol api manufacturer, veterinary phenicol api, florfenicol cas 76639-94-6, florfenicol aquaculture formulation

____________________________________________________________

Why Florfenicol Matters in Veterinary API

Florfenicol is one of the most widely used veterinary antibiotic APIs in global livestock, poultry, and aquaculture formulations. Its chemistry was specifically developed to retain the antimicrobial activity of the phenicol class while eliminating the human-safety concerns associated with chloramphenicol — most notably the risk of dose-independent aplastic anemia.

For B2B buyers in the veterinary medicinal product (VMP) space, florfenicol sits in a strategically different place than chloramphenicol or thiamphenicol. It is approved for veterinary use across the major regulatory jurisdictions, including the U.S., EU, China, Brazil, and most Asian markets, and it is the active ingredient in a wide range of dosage forms: water-soluble powders, oral solutions, premixes, and injectables.

Aquaculture — particularly in Asia-Pacific — is the single largest application market, driven by intensive shrimp and fish farming where florfenicol-based medicated feed and water treatments are widely used. For a B2B buyer evaluating the molecule, this means that the most significant demand pull comes from VMPs targeting food-animal species rather than companion animals.

Florfenicol API: Technical Profile

For buyers qualifying a new supplier, the following specifications are standard industry reference points.

Specifications above are typical industry reference ranges. Always confirm against the supplier's CoA and the monograph for your target market (USP, EP, ChP, or in-house standard).

Why Florfenicol Replaced Chloramphenicol in Veterinary Use

A short historical and structural note is useful for B2B buyers who need to understand why florfenicol is positioned the way it is in the global VMP market.

Chloramphenicol was widely used in both human and veterinary medicine for decades, until dose-independent aplastic anemia was identified as a rare but severe adverse effect in humans. As a result, chloramphenicol was effectively withdrawn from food-animal use across most major regulatory jurisdictions, and its use in companion animals was severely restricted.

Thiamphenicol, a related phenicol, was used as a partial substitute but is itself restricted in several markets due to similar hematological concerns. Florfenicol was developed by replacing the hydroxyl group on thiamphenicol with a fluorine atom — a small structural change that retained the antimicrobial spectrum while eliminating the human aplastic-anemia signal that had driven chloramphenicol's withdrawal.

For a B2B buyer, the practical consequence is that florfenicol is one of the few phenicol-class APIs with broad regulatory acceptance across food-animal species, which is why it now dominates the segment.

Aquaculture: The Largest Application Market

Aquaculture is the single largest end-use segment for florfenicol API globally. Intensive shrimp and finfish farming in China, Vietnam, Indonesia, Thailand, India, Ecuador, and several other countries generates sustained demand for florfenicol-based water-soluble powders and medicated feed premixes.

Why florfenicol in aquaculture specifically:- It is effective against many gram-negative aquatic pathogens at low inclusion rates, supporting cost-efficient medicated-feed formulations.- It has well-characterized withdrawal periods in major aquaculture species, simplifying regulatory compliance.- It is stable in typical aquaculture premix formulations under common storage conditions.

For B2B buyers serving the aquaculture market, the practical considerations are:- Withdrawal periods. Confirm against current local regulations in each target market; periods vary by species and formulation.- Medicated-feed premix formulation. Particle size, flowability, and homogeneity in feed are critical. Specify particle-size distribution explicitly when sourcing API.- Water-soluble formulations. Confirm solubility characteristics in the buffer or solvent system you intend to use; the API is not water-soluble and requires co-solvent or micronized grades for some applications.- Regional regulatory frameworks. Aquaculture VMP regulation is highly jurisdiction-specific. Buyers should confirm current status with local regulatory consultants.

Formulation Compatibility

Florfenicol API is well characterized for the following formulation types:

When developing a new VMP dossier, common pitfalls include:- Polymorphism. Florfenicol exists in known crystalline forms. Confirm with the supplier that the polymorphic form you receive is consistent across batches.- Solubility-limited bioavailability. Florfenicol is poorly water-soluble; formulation strategies may include micronization, co-solvents, or solid-dispersion approaches. The API particle size you source directly affects downstream formulation performance.- Stability in premix. Premix applications can introduce heat and moisture during feed-pelleting processes. Confirm with your supplier that the API is stable under your process conditions.

Global Regulatory Landscape

Florfenicol is approved for veterinary use across most major regulatory jurisdictions, but specific indications, withdrawal periods, and formulation restrictions vary widely.

1.  **United States.** FDA-approved VMPs exist for bovine respiratory disease and swine. Withdrawal periods are well documented.

2.  **European Union.** Florfenicol is approved for use in several food-animal species across EU member states. MRLs (maximum residue limits) and withdrawal periods are harmonized at the EU level.

3.  **China and Asia-Pacific.** China, Japan, South Korea, and most Southeast Asian markets have well-established florfenicol VMP frameworks. MRLs and withdrawal periods vary by species and jurisdiction.

4.  **Latin America.** Brazil, Mexico, Chile, and Ecuador — all major aquaculture producers — have national florfenicol VMP frameworks aligned with international standards.

For multi-market VMP manufacturers, the practical path is to source API at a single quality standard (USP, EP, or ChP) and document regional variations in the local dossier.

Supply Landscape and Manufacturing Complexity

Florfenicol API is supplied predominantly by Chinese manufacturers, with additional capacity in India and selected European manufacturers. The synthesis is moderately complex — multiple steps, chiral chemistry considerations, and fluorination chemistry that requires specialized equipment.

Typical lead times. 4–8 weeks for standard pack sizes (1–25 kg) from qualified manufacturers. Larger commercial quantities may require 10–14 weeks.

Common quality issues. Polymorphic-form inconsistency, residual solvents, and microbial limits are the three issues that show up most often in supplier audits. Always ask for the supplier's polymorphic-form data (XRPD or DSC), residual solvent profile, and microbial-limits report.

MOQ and pricing dynamics. MOQs typically range from 1 kg for R&D use to 25 kg or 50 kg for commercial supply. Pricing has been relatively stable, with modest downward pressure as additional Chinese capacity has come online.

Sourcing Checklist for B2B Buyers

A practical 6-step qualification workflow for florfenicol API:

1. Confirm target pharmacopeia. USP, EP, ChP, or in-house standard. Verify the supplier's monograph alignment and MRL-relevant impurity profile.

2. Request a sample CoA and full analytical package. Look for HPLC purity, related substances at ICH Q3A reporting thresholds, residual solvents per ICH Q3C, heavy metals, loss on drying, polymorphic form (XRPD or DSC), and microbial limits.

3. Verify polymorphism consistency. Florfenicol is known to exist in multiple crystalline forms. Confirm with the supplier that the form supplied is consistent across batches and matches your formulation's reference standard.

4. Audit manufacturing practices. On-site or remote audit covering GMP compliance, change-control history, impurity-tracking systems, and validated analytical methods.

5. Confirm documentation package. CoA, DMF/CEP/CDE reference letters where applicable, residual solvent profiles, microbial limits, and stability data covering the full retest interval.

6. Negotiate packaging and shipping. Validated ambient shipping with temperature loggers, GDP-compliant documentation, and clear packaging that protects the API from moisture and contamination.

Frequently Asked Questions (FAQ)

What is the CAS number for florfenicol?Florfenicol has CAS Number 76639-94-6.

What purity level is typical for florfenicol API?Industry standard purity is ≥ 99.0% by HPLC, with total impurities typically controlled to ≤ 1.0%. Final specifications should be aligned with your formulation's target pharmacopeia.

Why is florfenicol preferred over chloramphenicol in veterinary use?Florfenicol was developed as a fluorinated analog of thiamphenicol. It retains the antimicrobial spectrum of the phenicol class while eliminating the human aplastic-anemia signal that led to chloramphenicol's withdrawal from food-animal use.

What formulation types use florfenicol API?Water-soluble powders, oral solutions, premixes / medicated feed, and injectable solutions. Aquaculture and swine respiratory applications are the largest end-use segments.

Does florfenicol exist in multiple crystalline forms?Yes. Polymorphism is a known characteristic of florfenicol. B2B buyers should specify the desired polymorphic form and confirm batch-to-batch consistency via XRPD or DSC.

What packaging sizes are available?Standard pack sizes range from 1 kg for R&D use to 5 kg and 25 kg fiber drums for commercial supply. Custom packaging is typically available on request.

What storage conditions are required?Below 30 °C, in dry conditions, sealed container, protected from contamination. Retest intervals of 36 months are typical when stored under recommended conditions.

What regulatory considerations apply for aquaculture markets?Withdrawal periods and MRLs vary by species and jurisdiction. B2B buyers targeting aquaculture should confirm current local regulations with regional regulatory consultants.

Can florfenicol be used in companion-animal VMPs?Yes, in some jurisdictions. Indications and formulations vary. Confirm with local regulatory consultants for your target market.

About Our Florfenicol API Supply

Arshine VET supplies florfenicol API for veterinary medicinal product manufacturing, aquaculture formulations, and premix applications. Documentation packages are aligned to USP, EP, and ChP requirements, and our GMP-capable manufacturing partners provide full analytical support — including XRPD/DSC polymorphism characterization and validated light-protected packaging.

Contact: Arshine VET, Block 14, No.100, Luyun Road, Changsha 410205, Hunan, China. Email: info@arshinevet.com · Tel: 86-731-82294958 · WeChat: +86 188 7400 1228 · WhatsApp: +86 156 9731 1407.

____________________________________________________________

Sources & References

1.  Florfenicol pharmacology and pharmacopeial status — USP, EP, ChP monographs.

2.  EMA / CVMP positions on florfenicol use in veterinary medicine — published regulatory guidance.

3.  FDA-approved florfenicol VMP labels — published prescribing information.

4.  Phenicol chemistry and the structural rationale for florfenicol — peer-reviewed medicinal chemistry literature.

5.  ICH Q3A / Q3C guidance on impurities and residual solvents.

6.  Aquaculture pharmacotherapy reference standards — peer-reviewed aquaculture medicine literature.

7.  Florfenicol polymorphism and formulation implications — peer-reviewed pharmaceutical sciences literature.

8.  Chinese veterinary API export data — published industry summaries.

9.  MRL and withdrawal-period databases for florfenicol in food-animal species — published regulatory databases.